DK113389A - Monoklonale antistoffer - Google Patents

Monoklonale antistoffer

Info

Publication number
DK113389A
DK113389A DK113389A DK113389A DK113389A DK 113389 A DK113389 A DK 113389A DK 113389 A DK113389 A DK 113389A DK 113389 A DK113389 A DK 113389A DK 113389 A DK113389 A DK 113389A
Authority
DK
Denmark
Prior art keywords
antibodies
fragments
monoclonal antibodies
cell surface
human cell
Prior art date
Application number
DK113389A
Other languages
English (en)
Other versions
DK113389D0 (da
Inventor
Manfred Brockhaus
Hansruedi Loetscher
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of DK113389D0 publication Critical patent/DK113389D0/da
Publication of DK113389A publication Critical patent/DK113389A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2866—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for cytokines, lymphokines, interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DK113389A 1988-03-17 1989-03-08 Monoklonale antistoffer DK113389A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB888806339A GB8806339D0 (en) 1988-03-17 1988-03-17 Monoclonal antibodies

Publications (2)

Publication Number Publication Date
DK113389D0 DK113389D0 (da) 1989-03-08
DK113389A true DK113389A (da) 1989-09-18

Family

ID=10633598

Family Applications (1)

Application Number Title Priority Date Filing Date
DK113389A DK113389A (da) 1988-03-17 1989-03-08 Monoklonale antistoffer

Country Status (10)

Country Link
EP (1) EP0334165B1 (da)
JP (1) JPH02154695A (da)
AT (1) ATE132197T1 (da)
AU (1) AU618326B2 (da)
DE (1) DE68925226T2 (da)
DK (1) DK113389A (da)
GB (1) GB8806339D0 (da)
IE (1) IE890853L (da)
NZ (1) NZ228296A (da)
ZA (1) ZA891861B (da)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL83878A (en) * 1987-09-13 1995-07-31 Yeda Res & Dev Soluble protein corresponding to tnf inhibitory protein its preparation and pharmaceutical compositions containing it
IL94039A (en) * 1989-08-06 2006-09-05 Yeda Res & Dev Antibodies to tbp - 1 and their use
US5359037A (en) * 1988-09-12 1994-10-25 Yeda Research And Development Co. Ltd. Antibodies to TNF binding protein I
US7264944B1 (en) 1989-04-21 2007-09-04 Amgen Inc. TNF receptors, TNF binding proteins and DNAs coding for them
US6221675B1 (en) 1989-04-21 2001-04-24 Amgen, Inc. TNF receptors, TNF binding proteins and DNAs coding for them
EP0393438B1 (de) * 1989-04-21 2005-02-16 Amgen Inc. TNF-Rezeptor, TNF bindende Proteine und dafür kodierende DNAs
AU636608B2 (en) * 1989-05-18 1993-05-06 Yeda Research And Development Co. Ltd. Tumor necrosis factor binding protein II, it's purification and antibodies thereto
US6232446B1 (en) * 1989-05-18 2001-05-15 Yeda Research And Development Co. Ltd. TNF ligands
US6143866A (en) * 1989-07-18 2000-11-07 Amgen, Inc. Tumor necrosis factor (TNF) inhibitor and method for obtaining the same
IL95031A (en) 1989-07-18 2007-03-08 Amgen Inc A method of producing a recombinant human necrotic factor absorber
EP0491878B1 (en) * 1989-08-16 1997-02-19 Chiron Corporation Compositions for the inhibition of protein hormone formation and uses thereof
US5395760A (en) * 1989-09-05 1995-03-07 Immunex Corporation DNA encoding tumor necrosis factor-α and -β receptors
NZ235148A (en) * 1989-09-05 1991-12-23 Immunex Corp Tumour necrosis factor receptor protein and dna sequences
WO1991003553A1 (en) * 1989-09-05 1991-03-21 Immunex Corporation TUMOR NECROSIS FACTOR-α AND -β RECEPTORS
EP1132471A3 (de) * 1989-09-12 2001-11-28 F. Hoffmann-La Roche Ag TNF-bindende Proteine
DE4006269A1 (de) * 1990-02-28 1991-08-29 Max Planck Gesellschaft Antikoerper gegen den tumor-nekrosefaktor-rezeptor
US6552170B1 (en) 1990-04-06 2003-04-22 Amgen Inc. PEGylation reagents and compounds formed therewith
US5582998A (en) * 1991-06-19 1996-12-10 Boehringer Ingelheim International Gmbh Monoclonal antibodies against human TNF-binding protein I (TNF-BP I) and immunoassays therefor
DE59209888D1 (de) * 1991-06-19 2001-02-22 Boehringer Ingelheim Int Monoklonale antikörper gegen das humane tnf-bindende protein i (tnf-bp i)
ATE172880T1 (de) * 1992-08-28 1998-11-15 Bayer Ag Verwendung von monoklonalen anti-tnf-antikörpern für die behandlung von bakteriellen meningitiden
IT1270943B (it) * 1993-05-14 1997-05-26 Mini Ricerca Scient Tecnolog Anticorpi monoclonali anti-recettore di tipo i tnf alfa, procedimento per la produzione e loro usi
EP0791360A3 (en) * 1996-02-29 1997-09-24 Bayer Corporation Treatment of septic shock with anti-TNF antibodies
TW555765B (en) 1996-07-09 2003-10-01 Amgen Inc Low molecular weight soluble tumor necrosis factor type-I and type-II proteins
DK0942740T3 (da) 1996-12-06 2003-12-15 Amgen Inc Kombinationsterapi under anvendelse af et TFN-bindende protein til behandling af TFN-medierede sygdomme
US9028822B2 (en) 2002-06-28 2015-05-12 Domantis Limited Antagonists against TNFR1 and methods of use therefor
US10988543B2 (en) 2015-11-11 2021-04-27 Opi Vi—Ip Holdco Llc Humanized anti-tumor necrosis factor alpha receptor 2 (anti-TNFR2) antibodies and methods of use thereof to elicit an immune response against a tumor

Also Published As

Publication number Publication date
DE68925226D1 (de) 1996-02-08
IE890853L (en) 1989-09-17
DK113389D0 (da) 1989-03-08
ZA891861B (en) 1989-11-29
AU3125289A (en) 1989-09-21
EP0334165A2 (en) 1989-09-27
EP0334165B1 (en) 1995-12-27
AU618326B2 (en) 1991-12-19
NZ228296A (en) 1992-01-29
ATE132197T1 (de) 1996-01-15
DE68925226T2 (de) 1996-05-15
JPH02154695A (ja) 1990-06-14
EP0334165A3 (en) 1990-05-16
GB8806339D0 (en) 1988-04-13

Similar Documents

Publication Publication Date Title
ATE132197T1 (de) Monoklonale antikörper
FI973120A (fi) Ihmisen gp39:n eri epitoopeille spesifisiä monoklonaalisia vasta-aineita ja menetelmiä niiden käyttämiseksi diagnosoinnissa ja terapiassa
IE861543L (en) IgE-BF
DE69429092D1 (de) Verfahren zur kontrolle von b-zellenpopulation
ATE348113T1 (de) Rekombinanter anti-cd4 antikörper zur menschlichen behandlung
ATE169640T1 (de) Arzneimittelzusammensetzung zur behandlung oder vorbeugung maligner tumore
UA29494C2 (uk) Гуманізовані антитіла, способи їх продукування, спосіб лікування хвороби крона, спосіб лікування розсіяного склерозу, фармацевтична композиція
DE69326064D1 (de) Peptide des menschlichen Proteins P53 zum Gebrauch in menschlichen-zytotoxischen-T-Zell-Antwort-induzierenden Kompositionen sowie menschliche P53-Protein-spezifische T-Lymphocyten
FI900808A0 (fi) Humant mannos bindande protein.
EP0350690A3 (de) Neutralisation der in vitro- und in vivo-toxischen Eigenschaften von TNF-alfa durch monoklonale Antikörper und die davon abgeleiteten Fragmente
IL81370A (en) Pharmaceutical and diagnostic compositions comprising a plurality of human monoclonal antibodies for the treatment of bacterial diseases,methods for the preparation of the compositions and antibodies and kits containing said compositions
AU2002223462A1 (en) Use of cd28-specific monoclonal antibodies for stimulating blood cells that lackcd28
ATA111789A (de) Humaner monoklonaler antikörper und hybridom zur herstellung desselben
DK403384A (da) Enteralt effektivt, biologisk aktivt peptid- eller proteinmiddel ogfremgangsmaader til fremstilling deraf
EP0369816A3 (en) Monoclonal antibodies specific for human polymorphic epithelial mucin
SE9002212D0 (sv) Igg binding protein
FR2571146B1 (fr) Antigenes carcino-foetaux du pancreas humain et un procede de purification, antiserum contre ces antigenes et son procede de preparation et compositions diagnostiques les contenant
EP0780472A3 (en) Stress proteins
KR910006478A (ko) 인체 트립타제 유사 단백질
TH13774EX (th) รีคอมบิแนนท์แอนติบอดีสำหรับการรักษาโรคมนุษย์
NZ228194A (en) Monoclonal antibodies which bind to the n-terminal peptide sequence of the betasubunit of human haemoglobiin

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment